Meeder Asset Management Inc Meridian Bioscience Inc Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $3,955 - $4,294	128 Added 213.33%	188 $6,000
Q2 2022 Aug 08, 2022	SELL	$23.75 - $31.69 $261 - $348	-11 Reduced 15.49%	60 $2,000
Q1 2022 May 10, 2022	BUY	$19.97 - $26.94 $1,417 - $1,912	71 New	71 $2,000
Q4 2021 Feb 11, 2022	SELL	$17.46 - $21.61 $3,718 - $4,602	-213 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$17.35 - $22.5 $728 - $945	42 Added 24.56%	213 $4,000
Q2 2021 Aug 09, 2021	SELL	$18.01 - $28.32 $2,989 - $4,701	-166 Reduced 49.26%	171 $4,000
Q1 2021 Apr 28, 2021	BUY	$19.76 - $29.89 $6,283 - $9,505	318 Added 1673.68%	337 $9,000
Q4 2020 Feb 09, 2021	SELL	$15.73 - $21.66 $26,741 - $36,822	-1,700 Reduced 98.89%	19 $0
Q3 2020 Nov 02, 2020	SELL	$13.54 - $26.41 $17,168 - $33,487	-1,268 Reduced 42.45%	1,719 $29,000
Q2 2020 Aug 11, 2020	SELL	$7.84 - $23.29 $21,011 - $62,417	-2,680 Reduced 47.29%	2,987 $70,000
Q1 2020 May 15, 2020	SELL	$5.57 - $11.5 $3,648 - $7,532	-655 Reduced 10.36%	5,667 $49,000
Q4 2019 Feb 13, 2020	BUY	$7.9 - $10.14 $45,559 - $58,477	5,767 Added 1039.1%	6,322 $62,000
Q3 2019 Oct 17, 2019	SELL	$9.17 - $12.01 $110,269 - $144,420	-12,025 Reduced 95.59%	555 $5,000
Q2 2019 Aug 05, 2019	BUY	$10.88 - $17.6 $119,984 - $194,092	11,028 Added 710.57%	12,580 $150,000
Q1 2019 Apr 16, 2019	BUY	$15.51 - $17.61 $15,959 - $18,120	1,029 Added 196.75%	1,552 $27,000
Q4 2018 Jan 17, 2019	BUY	$14.52 - $19.72 $537 - $729	37 Added 7.61%	523 $9,000
Q3 2018 Nov 02, 2018	SELL	$14.85 - $16.35 $4,648 - $5,117	-313 Reduced 39.17%	486 $0
Q1 2018 May 03, 2018	SELL	$13.8 - $16.2 $1,738 - $2,041	-126 Reduced 13.62%	799 $11,000
Q4 2017 Feb 02, 2018	BUY	$13.55 - $15.8 $12,533 - $14,615	925	925 $12,000

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account